There are over 7,000 people who work at the campus, 900 hospital beds in the Royal Infirmary of Edinburgh and 1,200 researchers based across the site. By 2018, these numbers will rise to more than 1,300 hospital beds and over 2,000 researchers.

Developments at the campus over the next few years will see the £150m Royal Hospital for Children and Young People and Department of Clinical Neurosciences open in 2018. A new Centre for Tissue Repair will open in 2020, raising the number of stem cell scientists based here to one of the largest concentrations in the world.

The wide range of capabilities in life sciences concentrated at Edinburgh BioQuarter makes it a leading destination for translational medical research; advancing drug development by transforming basic scientific discoveries through clinical application, into new medical treatments and products. Academic research and clinical research facilities provide an opportunity for companies to engage with world-leading medical researchers and clinicians to progress new concepts from discovery, all the way through clinical trials, to establishing a commercially viable route to market.

With some of the best facilities in the country, such as ATMP GMP labs for stem-cell work, an imaging centre with PET, MRI and CT-slice scanners and an MHRA-accredited Phase I clinical trials unit on site as well as dedicated bio-incubator facilities.

Expertise

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G

Our partners

The Future

Projects at EBQ
Projects at EBQ

A masterplan for Edinburgh BioQuarter allocating space for new accommodation which would create a modern urban environment, including the potential for cafes, a hotel and gym received outline planning approval from the City of Edinburgh Council in 2013.

Edinburgh’s expanding BioQuarter is adding a new commercial facility to help meet demand for space. Work started in October 2017 on a new two-storey 1200 square metre modular building, which will provide a mix of specialist office and lab space. The building will open in early 2018 and is situated in the south of Edinburgh BioQuarter - adjacent to Nine and the Centre for Dementia Prevention.

The development follows on from the success of Nine, Edinburgh BioQuarter’s first commercial building, which opened in 2012 and is now fully occupied. Nine is home to over 20 innovative and award-winning Life Sciences businesses.

The value of construction projects currently (October 2017) taking place at Edinburgh BioQuarter is over £200m.

The University of Edinburgh’s £50m Centre for Tissue Repair will open in 2020. The new Centre will increase the number of stem cell scientists based at Edinburgh BioQuarter, making it one of the largest concentrations in the world.

NHS Lothian’s £150m Royal Hospital for Children and Young People and Department of Clinical Neurosciences is due to open in 2018. This relocation will bring many benefits to patient care and increased expertise to the campus.